These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 32193643)

  • 1. Diagnostic accuracy and potential covariates for machine learning to identify IDH mutations in glioma patients: evidence from a meta-analysis.
    Zhao J; Huang Y; Song Y; Xie D; Hu M; Qiu H; Chu J
    Eur Radiol; 2020 Aug; 30(8):4664-4674. PubMed ID: 32193643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Eur Radiol; 2019 Feb; 29(2):745-758. PubMed ID: 30003316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
    De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
    J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis.
    Chen X; Lei J; Wang S; Zhang J; Gou L
    Front Oncol; 2024; 14():1409760. PubMed ID: 39139289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
    J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Determination of
    Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A
    AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning for the Prediction of Molecular Markers in Glioma on Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
    Jian A; Jang K; Manuguerra M; Liu S; Magnussen J; Di Ieva A
    Neurosurgery; 2021 Jun; 89(1):31-44. PubMed ID: 33826716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
    Chen SC; Lo CM; Wang SH; Su EC
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between
    Okita Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Kinoshita M; Nonaka M; Fujinaka T; Kanemura Y
    Clin Radiol; 2020 Aug; 75(8):622-628. PubMed ID: 32321646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas.
    Zhang B; Chang K; Ramkissoon S; Tanguturi S; Bi WL; Reardon DA; Ligon KL; Alexander BM; Wen PY; Huang RY
    Neuro Oncol; 2017 Jan; 19(1):109-117. PubMed ID: 27353503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas.
    Suh CH; Kim HS; Park JE; Jung SC; Choi CG; Woo DC; Lee HB; Kim SJ
    Radiol Imaging Cancer; 2020 Jul; 2(4):e190083. PubMed ID: 33778723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application value of support vector machine model based on multimodal MRI in predicting IDH-1mutation and Ki-67 expression in glioma.
    Liang HX; Wang ZY; Li Y; Ren AN; Chen ZF; Wang XZ; Wang XM; Yuan ZG
    BMC Med Imaging; 2024 Sep; 24(1):244. PubMed ID: 39285364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
    Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
    Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning for prediction of isocitrate dehydrogenase mutation in gliomas: a critical approach, systematic review and meta-analysis of the diagnostic test performance using a Bayesian approach.
    Karabacak M; Ozkara BB; Mordag S; Bisdas S
    Quant Imaging Med Surg; 2022 Aug; 12(8):4033-4046. PubMed ID: 35919062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
    Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach.
    Yuan J; Siakallis L; Li HB; Brandner S; Zhang J; Li C; Mancini L; Bisdas S
    BMC Med Imaging; 2024 May; 24(1):104. PubMed ID: 38702613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.
    Lee MK; Park JE; Jo Y; Park SY; Kim SJ; Kim HS
    Eur Radiol; 2020 Feb; 30(2):844-854. PubMed ID: 31446467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion tensor imaging radiomics in lower-grade glioma: improving subtyping of isocitrate dehydrogenase mutation status.
    Park CJ; Choi YS; Park YW; Ahn SS; Kang SG; Chang JH; Kim SH; Lee SK
    Neuroradiology; 2020 Mar; 62(3):319-326. PubMed ID: 31820065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated machine learning to predict the co-occurrence of isocitrate dehydrogenase mutations and O
    Zhang S; Sun H; Su X; Yang X; Wang W; Wan X; Tan Q; Chen N; Yue Q; Gong Q
    J Magn Reson Imaging; 2021 Jul; 54(1):197-205. PubMed ID: 33393131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.